Suppr超能文献

膀胱容量增加在儿童难治性单症状性夜间遗尿症治疗中的价值

Value of increase in bladder capacity in treatment of refractory monosymptomatic nocturnal enuresis in children.

作者信息

De Wachter S, Vermandel A, De Moerloose K, Wyndaele J J

机构信息

Department of Urology, University Antwerp, Wilrijk, Belgium.

出版信息

Urology. 2002 Dec;60(6):1090-4. doi: 10.1016/s0090-4295(02)02127-1.

Abstract

OBJECTIVES

To evaluate children with refractory monosymptomatic nocturnal enuresis to determine whether detrusor overactivity (DOA) plays a role in 4 weeks of unsuccessful treatment with retention control training (RCT); whether an increase in bladder capacity can eventually be obtained by RCT plus oxybutynin; and whether the increase in capacity is the primary key to success.

METHODS

Sixty-eight children with refractory monosymptomatic nocturnal enuresis were included. They all had a maximal cystometric capacity less than the age-expected value. RCT was done by water loading and retention to the point of urgency once daily. During training, changes in bladder capacity were evaluated by voiding charts. If after 4 weeks of RCT, less than a 10% increase in bladder capacity was noted, oral oxybutynin was added.

RESULTS

The incidence of DOA was 66%. After 4 weeks of RCT, the bladder capacity increased in 20.6%. Combining RCT with oxybutynin led in the end to normalization of the bladder capacity in 79.4%. Older age and high-pressure DOA negatively influenced the ability to increase the bladder capacity. Fifteen children became completely dry, mainly by converting enuresis to nocturia.

CONCLUSIONS

Unsuccessful RCT is often caused by DOA, especially if a bladder capacity rise of at least 10% cannot be achieved within 4 weeks. If oxybutynin is added to the treatment, normalization of bladder capacity can be obtained in most. This increased bladder capacity cures enuresis only in a minority by sharpening their arousal and provoking nocturia.

摘要

目的

评估难治性单症状性夜间遗尿症患儿,以确定逼尿肌过度活动(DOA)在保留控制训练(RCT)治疗4周未成功的情况下是否起作用;RCT联合奥昔布宁最终是否能增加膀胱容量;以及容量增加是否是成功的主要关键因素。

方法

纳入68例难治性单症状性夜间遗尿症患儿。他们的最大膀胱测压容量均低于年龄预期值。RCT通过每日一次饮水并保留至尿急点来进行。训练期间,通过排尿图表评估膀胱容量的变化。如果RCT 4周后膀胱容量增加不到10%,则加用口服奥昔布宁。

结果

DOA的发生率为66%。RCT 4周后,20.6%的患儿膀胱容量增加。RCT联合奥昔布宁最终使79.4%的患儿膀胱容量恢复正常。年龄较大和高压DOA对增加膀胱容量的能力有负面影响。15名患儿完全不再尿床,主要是通过将遗尿转变为夜尿。

结论

RCT治疗失败通常由DOA引起,尤其是在4周内不能使膀胱容量至少增加10%的情况下。如果在治疗中加用奥昔布宁,大多数患儿的膀胱容量可恢复正常。这种增加的膀胱容量仅通过增强觉醒和诱发夜尿使少数患儿治愈遗尿症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验